Effects of Web-Based Education on Patient Empowerment and Asthma Control in Asthma Patients
1 other identifier
interventional
50
1 country
1
Brief Summary
Asthma is defined as a chronic inflammatory disorder of the airways associated with an extreme increase in airway hyperresponsiveness leading to recurrent wheezing, shortness of breath, chest tightness, and coughing attacks. The World Health Organization states that approximately 339 million individuals worldwide have asthma and more than 400 thousand deaths occur due to asthma every year. With effective and sustainable asthma management, it is possible to reduce disease-related complaints, admissions to emergency units and hospitalizations, limit the physiological and psychological effects of the disease, prevent dependence on healthcare professionals and caregivers, increase the quality of life and reduce the mortality of the disease. Patient education, which is within the educational role of professional nurses, is very important in asthma management. The research was planned in a single-center, randomized control group pretest-posttest design. The sample will consist of individuals who applied to the Allergy and Immunology clinic of Sureyyapasa Chest Diseases and Surgery Training and Research Hospital between May 2024 and January 2024, who have been diagnosed with asthma for at least one year and who accept the study \[25 intervention group - 25 control group\]. Groups will be determined using the random numbers table from the simple random sampling method. A web-based asthma education module will be created in line with the literature, and participants in the intervention group will be given synchronous training in 5 modules. After meeting the individuals in the intervention and control groups and obtaining verbal and written consent, they will be asked to fill out the Patient Information Form, Patient Empowerment Scale and Asthma Control Test prepared via Google Forms. A 30-minute training session will be given to the intervention group every week and there will be short evaluations after each training. When the 5th Module is completed, the intervention group will be asked to fill out the Patient Empowerment Scale and Asthma Control Test Scale. No intervention will be applied to the control group. 5. At the end of the module, the Patient Empowerment Scale and Asthma Control Test will be completed by individuals in the control group. It is thought that web-based asthma education that individuals will receive will positively affect their empowerment levels and increase their disease control.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable asthma
Started May 2024
Shorter than P25 for not_applicable asthma
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 12, 2024
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedStudy Start
First participant enrolled
May 30, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFebruary 21, 2024
February 1, 2024
1 month
February 12, 2024
February 12, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
patient empowerment scale (PES)
The scale consists of 37 items and five factors. Scale rating: 5-point Likert (1 = strongly disagree - 5 = strongly agree) The score that can be obtained from the scale varies between 37 and 185. As the score from the scale increases towards 5, patient empowerment is considered high, and as it decreases towards 1, patient empowerment is considered low.
five weeks
Secondary Outcomes (1)
Asthma Control Test (ACT)
five weeks
Study Arms (2)
intervention group
EXPERIMENTALIt will be determined using a table of random numbers. The group has been diagnosed for at least 1 year, It will consist of people (25) between the ages of 18-65, who can read and write in Turkish, who volunteer to participate in the study and who have not received any training before. After meeting the individuals and obtaining their verbal and written consent, they will be asked to fill out the Patient Information Form, Patient Empowerment Scale and Asthma Control Test obtained through Google Forms. Post-tests will be applied to individuals who complete all 5 modules of training.
Control group
ACTIVE COMPARATORThe participants will be individuals who apply to the Allergy and Immunology Clinic of Istanbul Sureyyapasa Chest Diseases and Surgery Training and Research Hospital, have been diagnosed with asthma for at least one year and agree to participate in the study. It will consist of people who are between the ages of 18-65, understand Turkish, know how to read and write. Twenty five people selected by the randomization table method will be in the control group. They will be given the Ministry of Health's asthma education brochure. As in the intervention group, pre-test and post-test will be conducted.
Interventions
Training presentations will be prepared in 5 modules by taking expert opinions in line with the literature. Training will be aimed at empowering patients to control asthma. It will include topics such as medication use, device use, exercise and disease management. Each week, an intervention group will be invited online to a module and the training will be given by the researcher.
The control group will not be given web-based training, but will be given the standard asthma education brochure of the Ministry of Health.
Eligibility Criteria
You may qualify if:
- Receiving treatment with a diagnosis of asthma for at least 1 year
- Having severe asthma
- Not having had any previous training
- Being between the ages of 18-65,
- Knowing how to read, write,
- Volunteering to participate in research
You may not qualify if:
- Having received treatment for less than 1 year
- Being educated,
- Not being at the level of severe asthma,
- Not meeting the age criterion,
- Not having the ability to understand, read and write Turkish
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sureyyapasa Chest Diseases and Thoracic Surgery Training and Research Hospital
Istanbul, 34854, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neslihan Komser
SUREYYAPASA CHEST DISEASES AND THORACIC SURGERY TRAINING AND RESEARCH HOSPITAL
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 12, 2024
First Posted
February 21, 2024
Study Start
May 30, 2024
Primary Completion
June 30, 2024
Study Completion
September 30, 2024
Last Updated
February 21, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share